Here’s the Reason Why Paratek Pharmaceuticals, Inc. (PRTK) Stock is Soaring in Aftermarket
Paratek Pharmaceuticals, Inc. (PRTK), a commercial-stage biopharmaceutical company, has surged 7.30% in aftermarket trading session. Consequently, PRTK stock is trading at $4.70 at the time